Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

When healthcare met politics with time running out: 3 new developments
The director of the National Institutes of Health and his principal deputy are touting their success at ‘curing’ the agency of its self-inflicted DEI disability.
FDA approves new nasal spray for patients with abnormal heart rhythms
Milestone Pharmaceuticals will be selling etripamil under the brand name Cardamyst. It is expected to hit the U.S. market in early 2026.
Philips to acquire AI-enabled intravascular imaging specialists SpectraWAVE
Massachusetts-based SpectraWAVE has gained considerable momentum in recent years, planting its flag in some of cardiology’s biggest trends. The company was co-founded by cardiologists and has already secured multiple FDA clearances.
American College of Radiology criticizes prominent study pushing for new approach to breast cancer screening
Published Friday in JAMA, scientists recently explored a risk-based mammography tactic that tailors regular imaging regimens to each individual’s danger of developing the disease.
Class action lawsuit claims imaging agent developer Telix Pharmaceuticals misled investors
Alleged transgressions took place between February and August, including the FDA rejecting Telix’s application for a new brain cancer imaging agent.

UnitedHealth Group’s Optum completes $8B merger with Change Healthcare

Optum has completed its nearly $8 billion merger with Change Healthcare, bringing an end to an embattled and controversial transaction.

Radiation oncology relatively low in ‘hazardous attitudes,’ although ‘macho’ makes the radar

The Federal Aviation Administration assesses pilots for five “hazardous attitudes” that may forewarn of risky behaviors in the air. Therapeutic radiology researchers have adapted the FAA scale for radiation oncologists making treatment decisions.

Formidable tumors tamed by genetically modified … herpes?

A genetically engineered iteration of the herpes simplex virus has beaten back several advanced cancers in an early trial.

New lesion measurement assesses treatment responses more accurately than RECIST

Researchers believe the new method of assessing treatment responses could pave the way for developing new cancer therapeutics.

Top 6 wealthiest Americans in healthcare

A number of healthcare industry folks were included in Forbes’ latest ranking of the wealthiest Americans in 2022.

AHA wins lawsuit over 340B payment cuts

The American Hospital Association (AHA) has claimed victory after the U.S. District Court for the District of Columbia ruled that the Department of Health and Human Services (HHS) must immediately halt payment cuts to the 340B Drug Pricing Program.

FDA recall. The medications involved are atenolol, which treats hypertension, and clopidogrel, which reduces the risk of an acute myocardial infarction (AMI) or stroke among patients with a history of AMI, severe chest pain or circulation problems.

FDA announces recall of 2 cardiovascular medications due to labeling mix-up

Patients face a risk of adverse events if they mistakenly take the wrong medication, according to a new warning from the FDA.

FDA clears 2D image-reconstruction product for 3D MRI

GE Healthcare may ship its deep learning-based image reconstruction software called AIR Recon DL with new 3D capabilities, the company announced Sept. 29.

Management

When healthcare met politics with time running out: 3 new developments

FDA approves new nasal spray for patients with abnormal heart rhythms

Philips to acquire AI-enabled intravascular imaging specialists SpectraWAVE

American College of Radiology criticizes prominent study pushing for new approach to breast cancer screening

Class action lawsuit claims imaging agent developer Telix Pharmaceuticals misled investors